These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2117284)
21. Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice. Maurer-Schultze B; Bassukas ID; Hofmockel G Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):65-78. PubMed ID: 7773138 [TBL] [Abstract][Full Text] [Related]
22. [Clinical trial of inhalant recombinant interferon-gamma in patients with pulmonary metastasis from renal tumor (preliminary report)]. Kawata N; Takimoto Y; Hirakata H; Fuse T; Hirano D; Yamanaka Y Hinyokika Kiyo; 1994 Sep; 40(9):773-6. PubMed ID: 7801837 [TBL] [Abstract][Full Text] [Related]
23. The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon. Small EJ; Weiss GR; Malik UK; Walther PJ; Johnson D; Wilding G; Kuzel T; Bajamonde A; Paton V Cancer J Sci Am; 1998; 4(3):162-7. PubMed ID: 9612597 [TBL] [Abstract][Full Text] [Related]
24. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Naito S; von Eschenbach AC; Giavazzi R; Fidler IJ Cancer Res; 1986 Aug; 46(8):4109-15. PubMed ID: 3731078 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of established human renal cell carcinoma--experimental treatment with interferon and UFT]. Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1498-502. PubMed ID: 3141533 [No Abstract] [Full Text] [Related]
27. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts. Gridley DS; Slater JM; Stickney DR J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378 [TBL] [Abstract][Full Text] [Related]
28. Retinoids and metastatic renal cell carcinoma. Paule B; Brion N Ann Med Interne (Paris); 1997; 148(7):496-501. PubMed ID: 9538388 [TBL] [Abstract][Full Text] [Related]
29. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy. Pak AS; Ip G; Wright MA; Young MR Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804 [TBL] [Abstract][Full Text] [Related]
30. Effects of cytotoxic drugs on tumor marker secretion of gastrointestinal/pancreatic carcinomas--comparison of studies in nude mice and in patients. Klapdor U; Klapdor R; Bahlo M; Franke N; Hirschmann M Strahlenther Onkol; 1989 Jul; 165(7):550-2. PubMed ID: 2501887 [No Abstract] [Full Text] [Related]
31. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon. Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820 [TBL] [Abstract][Full Text] [Related]
32. Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft. Hubbell HR; Pequignot EC; Shanabrook KR; Carter WA; Williams RD; Strayer DR Anticancer Res; 1990; 10(3):795-801. PubMed ID: 2369093 [TBL] [Abstract][Full Text] [Related]
33. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein. Nanus DM; Pfeffer LM; Bander NH; Bahri S; Albino AP Cancer Res; 1990 Jul; 50(14):4190-4. PubMed ID: 2364374 [TBL] [Abstract][Full Text] [Related]
34. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma. Fraker DL; Alexander HR Important Adv Oncol; 1994; ():179-92. PubMed ID: 8206489 [No Abstract] [Full Text] [Related]
35. Effect of recombinant interferon alfa on bone metastases of renal-cell carcinoma. Fosså SD; Lien HH; Lindegaard M N Engl J Med; 1991 Feb; 324(9):633-4. PubMed ID: 1992326 [No Abstract] [Full Text] [Related]
36. A study on direct antitumor activity of bropirimine (oral interferon inducer) for renal cell carcinoma. Onishi T; Machida T Hinyokika Kiyo; 1994 Mar; 40(3):195-200. PubMed ID: 8178735 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581 [TBL] [Abstract][Full Text] [Related]
38. Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma. Tatsugami K; Eto M; Harano M; Hamaguchi M; Miyamoto T; Morisaki T; Furue M; Akashi K; Naito S Int J Urol; 2008 Aug; 15(8):694-8. PubMed ID: 18564205 [TBL] [Abstract][Full Text] [Related]
39. In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts. Beniers AJ; Peelen WP; Hendriks BT; Schalken JA; Romijn JC; Debruyne FM Urol Res; 1988; 16(4):309-14. PubMed ID: 2459829 [TBL] [Abstract][Full Text] [Related]
40. [Anti-tumor effect of human recombinant tumor necrosis factor on the human renal cell carcinoma serially transplanted into nude mice]. Honda N; Yamada Y; Muramatsu T; Fukatsu H; Segawa A Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1613-21. PubMed ID: 3251094 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]